Wednesday, June 24, 2020

Carlsmed Finds $2.5M For Spine Surgery

San Diego-based Carlsmed, a developer of medical devices to improve complex spin surgery, has raised $2.5M in a funding round, the company said on Tuesday. The seed funding was led by Cove Fund II, and also included Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as un-named angels. According to the company, it will use the financing to accelerate clinial launch of its system for personalized spine surgery. As part of the funding, the company said it appointed Alexander Arrow, MD, CFA, as Chief Financial Officer and Shariq Hussain as Chief Information Officer. Arrow previously served at such companies at Protagenic Therapeutis, elegent, and Biolase; Hussaine previously was co-founder, CEO, and CTO of IntelliGuard and also served at Safety Syringes. Carlsmed is one of the companies in the EvoNexus startup incubator.